NMPA Approval

Naphazoline Hydrochloride Nasal Drops

Approval Number

国药准字H20247279

Company石家庄格瑞药业有限公司

Registration Date

November 7, 2024

Previous Approval Numbers

国药准字H13024618

Drug Information

Generic Name

盐酸萘甲唑啉滴鼻液

Dosage Form

滴鼻剂

Strength

0.1%(10ml:10mg)

Drug Type

化学药品

Registration Date

November 7, 2024

Company Information

Applicant Company

Company Name石家庄格瑞药业有限公司

Company Address

石家庄高新区秦岭大街588号

Manufacturing Company

Company Name石家庄格瑞药业有限公司

Company Address

石家庄高新区秦岭大街588号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸萘甲唑啉滴鼻液 - NMPA 批准文号 | MedPath